The FDA has approved Apollo Endosurgery’s latest product: a minimally invasive gastrointestinal balloon to combat obesity.
The Orbera device is inserted through a patient’s mouth into the stomach where it is inflated and filled with saline. Dennis McWilliams, Apollo’s president and CEO, says the device is a sort of mid-point therapy to combat obesity, in between diet and exercise, and more invasive procedures such as gastric bypass surgery.
Help employers find you! Check out all the jobs and post your resume.
